Here Are A Few Things To Feel Optimistic About Right Now

From vaccine advancement to cleaner air, these positives are worth focusing on amid this coronavirus pandemic.
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news

Related Links:

The United Nations and the International Red Cross and Red Crescent Movement are urging that governments and others unite in developing a “people’s vaccine” to protect everyone against the coronavirus
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Conclusion Medical device specialists want to help, but responding to pandemic shortages can be complicated. These takeaways come from our experience with building PPE, but they apply to any collaborative rapid response project. Use these tips as a framework to get you and your team on the path to meaningful progress.
Source: MDDI - Category: Medical Devices Authors: Tags: Design Source Type: news
Eunice G. Kamwendo is an Economist and Strategic Advisor with UNDP Africa in New York. Chaltu Daniel Kalbessa is a UNDP Fellow and Strategic Analyst with UNDP Africa in New York.By Eunice G. Kamwendo and Chaltu Daniel KalbessaNEW YORK, Jun 3 2020 (IPS) With very weak health systems and overall capacity constraints to effectively respond to the deadly coronavirus disease, Africa’s fate against the invisible enemy, was going to be nothing short of catastrophic according to early predictions. Although Africa is yet to reach its peak, many countries are not seeing the exponential growth in case numbers, or in mortality r...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Africa Aid Headlines Health Humanitarian Emergencies TerraViva United Nations Source Type: news
Vidya M Mahalmani, Dhruv Mahendru, Ankita Semwal, Sukhmeet Kaur, Harpinder Kaur, Phulen Sarma, Ajay Prakash, Bikash MedhiIndian Journal of Pharmacology 2020 52(2):117-129 In December 2019, severe acute respiratory syndrome-coronavirus-2, a novel coronavirus, initiated an outbreak of pneumonia from Wuhan in China, which rapidly spread worldwide. The clinical characteristics of the disease range from asymptomatic cases or mild symptoms, which include nonspecific symptoms such as fever, cough, sore throat, headache, and nasal congestion to severe cases such as pneumonia, respiratory failure demanding mechanical ventilation t...
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research
The objective of this article is to review and discuss the possible role of these drugs in the therapy of COVID-19.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
While confirmed cases of infections of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease ’s damage. Although no proven effective therapies to treat COVID-19 patients or for managing their complications currently exist, the rapidly expanding knowledge regarding severe acute respiratory syndrome–coronavirus 2 and its interplay with hosts provide a significant number of potential drug targets, and the potential to repurpose drugs already tested in other diseases.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Current Perspective Source Type: research
TUESDAY, June 2, 2020 -- In a finding that could help guide the response to the coronavirus pandemic, new research shows that a measles outbreak that struck New York City last year could have been much worse if the city had not launched a vaccine...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Much remains unknown and mysterious, but these are some of the things we ’re pretty sure of after half a year of this pandemic.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Coronavirus Reopenings Research Medicine and Health Science and Technology Vaccination and Immunization Quarantines Masks Tests (Medical) Antibodies Protective Clothing and Gear your-feed-science your-feed-h Source Type: news
Sometimes when the discussion of tackling the novel coronavirus comes up, the use of medical devices gets lost in the shuffle. Most of the conversation surrounding COVID-19 comes from either the promise of a vaccine or the expansion of tests. Abiomed is adding to the conversation surrounding medtech’s potential contribution to the treatment of COVID-19 patients. Monday, the Danvers, MA-based company by receiving Emergency Use Authorization for a device to treat COVID-19 related right heart failure patients. The Impella RP is a temporary heart pump that provides circulatory support for patients who develop...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular COVID-19 Source Type: news
The ongoing severe respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic puts a large strain on public healthcare systems worldwide. Given that effective treatments and vaccines are not yet available, it is of utmost importance to elucidate potential routes of SARS-CoV-2 transmission to device effective transmission-based precautions. Ye et al. recently described SARS-CoV-2 contaminated surfaces in COVID-19 patient care areas in a hospital environment1. Moreover, infectious virus has been shown to persist on surfaces for several hours to days at room temperature (RT)2.
Source: Journal of Infection - Category: Infectious Diseases Authors: Source Type: research
More News: Coronavirus | COVID-19 | Health | Pandemics | Vaccines